Jun 15, 2020
FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD
Jun 09, 2020
Academic Accommodations May Rise Following Pandemic, according to the Cognitive Assessment Group
May 13, 2020
Arbor Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application (NDA) for AR19, an Investigational ADHD Prescription Stimulant Treatment Specifically Designed to Resist Physical Manipulation for Nonmedical Misuse or Abuse
Mar 17, 2020
Quillivant XR®, QuilliChew ER® and Dyanavel® XR are 100% Made in the U.S.A. and Remain Consistently Supplied During COVID-19 Pandemic
Mar 09, 2020
Outlook on the Attention Deficit Hyperactivity Disorder (ADHD) Market to 2026
Feb 11, 2020
Teens with a History of ADHD Need Stronger Monitoring of Health Risks
Feb 07, 2020
Children with ADHD more likely to receive medication if they live in poorer areas
Jan 24, 2020
Ontario continues to improve access to treatment for children and adolescents living with ADHD who are prescribed INTUNIV XR®*
Jan 17, 2020
APSARD and Tris Pharma Announce the Inaugural Tris Research Award in ADHD
Dec 11, 2019
RSNA: Artificial Intelligence Boosts MRI Detection of ADHD
Nov 27, 2019
Visiongain Launches Report Examining the Potential in the $17bn Attention Deficit Hyperactivity Disorder Drugs Market
Nov 20, 2019
Chicagoland's Clarity Clinic Seeks to Change Public Discourse on Treating Pain and Addiction, as We Approach Holiday Season
Oct 15, 2019
Smart Kids Hosts Conference for Parents of Children with LD and ADHD
Sep 12, 2019
The Children's School Opens New Program In Irvine For Children With ADHD And Related Challenges With Executive Functioning
Sep 04, 2019
Tris Pharma Strengthens Its Branded Commercial Leadership Team
Aug 22, 2019
Dr. Derek Loewy to Speak about Latest Findings in Reducing Medications for Insomnia
Aug 13, 2019
RSNA: ADHD Medication May Affect Brain Development in Children
Jun 18, 2019
ADHD Product Sees Top Rating from TopConsumerReviews.com
May 22, 2019
Bened Biomedical Co., Ltd.: Psychobiotic PS128(TM) found to be a potential solution for Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD)
May 20, 2019
Teens with ADHD Get More Traffic Violations for Risky Driving, Have Higher Crash Risk Regardless of Age When Licensed